Compare
Amgen vs Halozyme (AMGN vs HALO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amgen (AMGN) returned +43.9% and Halozyme (HALO) +51.7%; so far this year the figures are +40.7% and +54.0%.
Amgen is the larger company by market value, about 21.1 times the size of Halozyme.
On trailing earnings, AMGN trades at 26.7 times and HALO at 25.8 times.
Revenue grew +8.2% at AMGN and +45.0% at HALO over the last year.
AMGN yields 2.16%. HALO pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| AMGN | HALO | |
|---|---|---|
| Price | $460.42 | $103.63 |
| 1-day | +0.03% | -15.72% |
| YTD | +40.67% | +53.98% |
| 1 year | +43.94% | +51.73% |
| 3 years | +76.51% | +209.25% |
| Market cap | $249.1B | $11.8B |
| P/E | 26.7 | 25.8 |
| P/S | 6.40 | 6.55 |
| P/B | 17.35 | — |
| Revenue growth | +8.20% | +45.00% |
| EPS growth | +33.30% | -15.60% |
| Gross margin % | 70.9 | 82.3 |
| Net margin % | 24.1 | 26.9 |
| ROE % | 65.4 | — |
| Debt / equity | 3.76 | — |
| FCF yield % | 3.8 | 7.5 |
| Dividend yield % | 2.16 | — |
| Beta | 0.50 | 0.59 |
| RSI (14) | 60.5 | 29.2 |
| Technical rating |